Novel motif:124: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif124_AATNCANCACT
|novel_motifs_human_sample_pval=11376-118A8_11051;0.558443,11327-117E4_11969;0.933122,11473-119C6_11054;0.587384,11474-119C7_12067;0...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:12, 9 September 2013
name: | motif124_AATNCANCACT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0034332 | adherens junction organization | 4.676747e-15 |
GO:0050896 | response to stimulus | 8.128399e-15 |
GO:0048583 | regulation of response to stimulus | 1.587519e-13 |
GO:0070584 | mitochondrion morphogenesis | 3.253570e-13 |
GO:0006955 | immune response | 5.038678e-13 |
GO:0023052 | signaling | 5.292504e-13 |
GO:0002376 | immune system process | 6.718726e-13 |
GO:0007165 | signal transduction | 6.756497e-13 |
GO:0007154 | cell communication | 7.040683e-13 |
GO:0051716 | cellular response to stimulus | 2.768604e-12 |
GO:0065008 | regulation of biological quality | 1.652654e-11 |
GO:0070972 | protein localization in endoplasmic reticulum | 3.910387e-11 |
GO:0045216 | cell-cell junction organization | 4.273008e-11 |
GO:0007166 | cell surface receptor linked signaling pathway | 5.157190e-11 |
GO:0032501 | multicellular organismal process | 2.442033e-10 |
GO:0034329 | cell junction assembly | 2.747252e-10 |
GO:0006626 | protein targeting to mitochondrion | 1.149764e-9 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.573204e-9 |
GO:0033036 | macromolecule localization | 1.786731e-9 |
GO:0034330 | cell junction organization | 2.189839e-9 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 3.327249e-9 |
GO:0007275 | multicellular organismal development | 3.732867e-9 |
GO:0006621 | protein retention in ER lumen | 6.870480e-9 |
GO:0070585 | protein localization in mitochondrion | 7.552075e-9 |
GO:0008104 | protein localization | 7.776208e-9 |
GO:0072655 | establishment of protein localization in mitochondrion | 7.887131e-9 |
GO:0048513 | organ development | 8.278199e-9 |
GO:0048518 | positive regulation of biological process | 9.035453e-9 |
GO:0021572 | rhombomere 6 development | 1.142648e-8 |
GO:0032502 | developmental process | 1.260300e-8 |
GO:0051336 | regulation of hydrolase activity | 1.464655e-8 |
GO:0045321 | leukocyte activation | 1.761741e-8 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 2.017845e-8 |
GO:0006952 | defense response | 2.242763e-8 |
GO:0042403 | thyroid hormone metabolic process | 2.741257e-8 |
GO:0070050 | neuron homeostasis | 3.163111e-8 |
GO:0006612 | protein targeting to membrane | 3.296047e-8 |
GO:0002706 | regulation of lymphocyte mediated immunity | 3.716477e-8 |
GO:0033365 | protein localization to organelle | 4.461418e-8 |
GO:0042110 | T cell activation | 4.758896e-8 |
GO:0009913 | epidermal cell differentiation | 6.269384e-8 |
GO:0071634 | regulation of transforming growth factor beta production | 6.346441e-8 |
GO:0048856 | anatomical structure development | 6.618919e-8 |
GO:0001819 | positive regulation of cytokine production | 7.094939e-8 |
GO:0045040 | protein import into mitochondrial outer membrane | 7.383440e-8 |
GO:0042445 | hormone metabolic process | 7.557807e-8 |
GO:0045766 | positive regulation of angiogenesis | 7.926618e-8 |
GO:0035621 | ER to Golgi ceramide transport | 7.982914e-8 |
GO:0032101 | regulation of response to external stimulus | 1.020525e-7 |
GO:0051270 | regulation of cellular component movement | 1.057842e-7 |
GO:0048731 | system development | 1.059735e-7 |
GO:0001952 | regulation of cell-matrix adhesion | 1.066097e-7 |
GO:0002682 | regulation of immune system process | 1.197280e-7 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 1.264918e-7 |
GO:0072594 | establishment of protein localization to organelle | 1.279991e-7 |
GO:0042221 | response to chemical stimulus | 1.564899e-7 |
GO:0048630 | skeletal muscle tissue growth | 1.626688e-7 |
GO:0042592 | homeostatic process | 1.839806e-7 |
GO:0045765 | regulation of angiogenesis | 1.894823e-7 |
GO:0006605 | protein targeting | 2.113010e-7 |
GO:0002885 | positive regulation of hypersensitivity | 2.635099e-7 |
GO:0030216 | keratinocyte differentiation | 3.369833e-7 |
GO:0051179 | localization | 3.480711e-7 |
GO:0050776 | regulation of immune response | 3.523247e-7 |
GO:0040012 | regulation of locomotion | 3.681285e-7 |
GO:0007005 | mitochondrion organization | 3.862986e-7 |
GO:0010817 | regulation of hormone levels | 3.867747e-7 |
GO:0006590 | thyroid hormone generation | 3.966899e-7 |
GO:0031641 | regulation of myelination | 4.038871e-7 |
GO:0048522 | positive regulation of cellular process | 4.126423e-7 |
GO:2000145 | regulation of cell motility | 4.287227e-7 |
GO:0001970 | positive regulation of activation of membrane attack complex | 4.374365e-7 |
GO:0023051 | regulation of signaling | 4.475781e-7 |
GO:0046716 | muscle cell homeostasis | 4.481278e-7 |
GO:0045056 | transcytosis | 4.493270e-7 |
GO:2000146 | negative regulation of cell motility | 5.186238e-7 |
GO:0030336 | negative regulation of cell migration | 5.327142e-7 |
GO:0002703 | regulation of leukocyte mediated immunity | 5.888134e-7 |
GO:0051271 | negative regulation of cellular component movement | 6.322929e-7 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 6.351379e-7 |
GO:0070613 | regulation of protein processing | 7.637720e-7 |
GO:0050766 | positive regulation of phagocytosis | 8.282006e-7 |
GO:0050793 | regulation of developmental process | 8.770449e-7 |
GO:0032879 | regulation of localization | 9.258649e-7 |
GO:0030334 | regulation of cell migration | 9.497591e-7 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 1.028797e-6 |
GO:0009268 | response to pH | 1.132971e-6 |
GO:0007267 | cell-cell signaling | 1.159776e-6 |
GO:0051893 | regulation of focal adhesion assembly | 1.162106e-6 |
GO:0022407 | regulation of cell-cell adhesion | 1.278853e-6 |
GO:0030878 | thyroid gland development | 1.330169e-6 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 1.363757e-6 |
GO:0002709 | regulation of T cell mediated immunity | 1.419663e-6 |
GO:0046649 | lymphocyte activation | 1.487542e-6 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 1.514649e-6 |
GO:0002883 | regulation of hypersensitivity | 1.558982e-6 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.685351e-6 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.803495e-6 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.880773e-6 |
GO:0048468 | cell development | 1.936457e-6 |
GO:0001654 | eye development | 1.960261e-6 |
GO:0072376 | protein activation cascade | 1.989450e-6 |
GO:0046578 | regulation of Ras protein signal transduction | 1.995367e-6 |
GO:0050789 | regulation of biological process | 2.074484e-6 |
GO:0040013 | negative regulation of locomotion | 2.089983e-6 |
GO:0015031 | protein transport | 2.321496e-6 |
GO:0048584 | positive regulation of response to stimulus | 2.703209e-6 |
GO:0032318 | regulation of Ras GTPase activity | 2.720702e-6 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 3.302736e-6 |
GO:0042178 | xenobiotic catabolic process | 3.544265e-6 |
GO:0048869 | cellular developmental process | 3.589194e-6 |
GO:0010954 | positive regulation of protein processing | 3.669333e-6 |
GO:0006184 | GTP catabolic process | 3.788947e-6 |
GO:0070727 | cellular macromolecule localization | 3.790913e-6 |
GO:0042098 | T cell proliferation | 3.797002e-6 |
GO:0034613 | cellular protein localization | 3.965754e-6 |
GO:0007156 | homophilic cell adhesion | 4.078180e-6 |
GO:0045834 | positive regulation of lipid metabolic process | 4.417627e-6 |
GO:0007423 | sensory organ development | 4.597697e-6 |
GO:0017038 | protein import | 4.882954e-6 |
GO:0030449 | regulation of complement activation | 5.076239e-6 |
GO:0048732 | gland development | 5.281701e-6 |
GO:0006958 | complement activation, classical pathway | 5.414634e-6 |
GO:0042462 | eye photoreceptor cell development | 5.996158e-6 |
GO:0050877 | neurological system process | 6.276163e-6 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 6.364837e-6 |
GO:0033561 | regulation of water loss via skin | 6.455358e-6 |
GO:0046039 | GTP metabolic process | 7.007592e-6 |
GO:0051641 | cellular localization | 7.364990e-6 |
GO:0001953 | negative regulation of cell-matrix adhesion | 7.586606e-6 |
GO:0051494 | negative regulation of cytoskeleton organization | 7.659070e-6 |
GO:0015705 | iodide transport | 8.052872e-6 |
GO:0001775 | cell activation | 8.269655e-6 |
GO:0031347 | regulation of defense response | 9.100673e-6 |
GO:0065009 | regulation of molecular function | 9.441228e-6 |
GO:0045410 | positive regulation of interleukin-6 biosynthetic process | 9.753657e-6 |
GO:0071786 | endoplasmic reticulum tubular network organization | 1.004196e-5 |
GO:0002088 | lens development in camera-type eye | 1.016885e-5 |
GO:0009888 | tissue development | 1.023020e-5 |
GO:0009988 | cell-cell recognition | 1.042520e-5 |
GO:0051128 | regulation of cellular component organization | 1.063717e-5 |
GO:0030155 | regulation of cell adhesion | 1.109635e-5 |
GO:0050790 | regulation of catalytic activity | 1.117189e-5 |
GO:0042446 | hormone biosynthetic process | 1.121585e-5 |
GO:0080134 | regulation of response to stress | 1.123170e-5 |
GO:0045184 | establishment of protein localization | 1.146555e-5 |
GO:0072595 | maintenance of protein localization to organelle | 1.177771e-5 |
GO:0030154 | cell differentiation | 1.247619e-5 |
GO:0021571 | rhombomere 5 development | 1.258227e-5 |
GO:0050794 | regulation of cellular process | 1.316846e-5 |
GO:0070887 | cellular response to chemical stimulus | 1.379262e-5 |
GO:0018958 | phenol-containing compound metabolic process | 1.383282e-5 |
GO:0019933 | cAMP-mediated signaling | 1.396794e-5 |
GO:0008544 | epidermis development | 1.426051e-5 |
GO:0032938 | negative regulation of translation in response to oxidative stress | 1.437359e-5 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 1.441577e-5 |
GO:0045006 | DNA deamination | 1.563567e-5 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 1.570841e-5 |
GO:0046651 | lymphocyte proliferation | 1.625330e-5 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 1.682738e-5 |
GO:0042461 | photoreceptor cell development | 1.804551e-5 |
GO:0006810 | transport | 1.818091e-5 |
GO:0002456 | T cell mediated immunity | 1.853072e-5 |
GO:0044093 | positive regulation of molecular function | 1.917674e-5 |
GO:0015889 | cobalamin transport | 1.965591e-5 |
GO:0006935 | chemotaxis | 1.971834e-5 |
GO:0050764 | regulation of phagocytosis | 2.143411e-5 |
GO:0010646 | regulation of cell communication | 2.216559e-5 |
GO:0035270 | endocrine system development | 2.315554e-5 |
GO:0032320 | positive regulation of Ras GTPase activity | 2.383691e-5 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 2.481428e-5 |
GO:2000026 | regulation of multicellular organismal development | 2.516126e-5 |
GO:0051234 | establishment of localization | 2.528793e-5 |
GO:0032943 | mononuclear cell proliferation | 2.585807e-5 |
GO:0048521 | negative regulation of behavior | 2.599700e-5 |
GO:0046463 | acylglycerol biosynthetic process | 2.663209e-5 |
GO:0043010 | camera-type eye development | 2.742382e-5 |
GO:0006140 | regulation of nucleotide metabolic process | 2.773217e-5 |
GO:0032368 | regulation of lipid transport | 2.798266e-5 |
GO:0046755 | non-lytic virus budding | 2.845416e-5 |
GO:0060341 | regulation of cellular localization | 2.908157e-5 |
GO:0010765 | positive regulation of sodium ion transport | 2.948480e-5 |
GO:0006956 | complement activation | 2.955885e-5 |
GO:0035690 | cellular response to drug | 2.958764e-5 |
GO:0030217 | T cell differentiation | 3.021941e-5 |
GO:0090003 | regulation of establishment of protein localization in plasma membrane | 3.051608e-5 |
GO:0009653 | anatomical structure morphogenesis | 3.086053e-5 |
GO:0007190 | activation of adenylate cyclase activity | 3.169257e-5 |
GO:0050663 | cytokine secretion | 3.334812e-5 |
GO:0090273 | regulation of somatostatin secretion | 3.437419e-5 |
GO:0001817 | regulation of cytokine production | 3.488433e-5 |
GO:0065007 | biological regulation | 3.497084e-5 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 3.515199e-5 |
GO:0071466 | cellular response to xenobiotic stimulus | 3.531843e-5 |
GO:0051239 | regulation of multicellular organismal process | 3.534403e-5 |
GO:0050808 | synapse organization | 3.774354e-5 |
GO:0070206 | protein trimerization | 3.822147e-5 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 3.897223e-5 |
GO:0042537 | benzene-containing compound metabolic process | 3.909810e-5 |
GO:0006805 | xenobiotic metabolic process | 3.969776e-5 |
GO:0046504 | glycerol ether biosynthetic process | 3.991282e-5 |
GO:0044281 | small molecule metabolic process | 4.100101e-5 |
GO:0043154 | negative regulation of caspase activity | 4.114292e-5 |
GO:0019432 | triglyceride biosynthetic process | 4.148659e-5 |
GO:0007029 | endoplasmic reticulum organization | 4.326166e-5 |
GO:0032851 | positive regulation of Rab GTPase activity | 4.440055e-5 |
GO:0009966 | regulation of signal transduction | 4.510691e-5 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 4.588019e-5 |
GO:0071622 | regulation of granulocyte chemotaxis | 4.609789e-5 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 4.652028e-5 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 4.669377e-5 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 4.724647e-5 |
GO:0060249 | anatomical structure homeostasis | 4.842662e-5 |
GO:0007043 | cell-cell junction assembly | 4.848804e-5 |
GO:0007292 | female gamete generation | 4.908138e-5 |
GO:0038003 | opioid receptor signaling pathway | 4.936786e-5 |
GO:0006629 | lipid metabolic process | 4.993196e-5 |
GO:0018149 | peptide cross-linking | 5.014018e-5 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 5.138595e-5 |
GO:0030814 | regulation of cAMP metabolic process | 5.158163e-5 |
GO:0019216 | regulation of lipid metabolic process | 5.162478e-5 |
GO:0031281 | positive regulation of cyclase activity | 5.493730e-5 |
GO:0051349 | positive regulation of lyase activity | 5.691214e-5 |
GO:0070661 | leukocyte proliferation | 5.763747e-5 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5.853829e-5 |
GO:0010034 | response to acetate | 5.853829e-5 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 6.050085e-5 |
GO:0048469 | cell maturation | 6.179853e-5 |
GO:2000191 | regulation of fatty acid transport | 6.222136e-5 |
GO:0009894 | regulation of catabolic process | 6.224827e-5 |
GO:0071260 | cellular response to mechanical stimulus | 6.348725e-5 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 6.433129e-5 |
GO:0010574 | regulation of vascular endothelial growth factor production | 6.457006e-5 |
GO:0070201 | regulation of establishment of protein localization | 6.723012e-5 |
GO:0010639 | negative regulation of organelle organization | 6.926022e-5 |
GO:0070163 | regulation of adiponectin secretion | 6.995524e-5 |
GO:0030728 | ovulation | 7.125637e-5 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 7.153544e-5 |
GO:0050727 | regulation of inflammatory response | 7.175597e-5 |
GO:0060429 | epithelium development | 7.175955e-5 |
GO:0071310 | cellular response to organic substance | 7.200653e-5 |
GO:0045762 | positive regulation of adenylate cyclase activity | 7.223118e-5 |
GO:0048709 | oligodendrocyte differentiation | 7.387318e-5 |
GO:0001525 | angiogenesis | 7.431879e-5 |
GO:0009410 | response to xenobiotic stimulus | 7.443467e-5 |
GO:0043085 | positive regulation of catalytic activity | 7.484146e-5 |
GO:0006620 | posttranslational protein targeting to membrane | 7.528042e-5 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 7.528042e-5 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 7.659548e-5 |
GO:0071345 | cellular response to cytokine stimulus | 8.131703e-5 |
GO:0032066 | nucleolus to nucleoplasm transport | 8.179299e-5 |
GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway | 8.179299e-5 |
GO:0071675 | regulation of mononuclear cell migration | 8.234875e-5 |
GO:0019932 | second-messenger-mediated signaling | 8.308609e-5 |
GO:0007289 | spermatid nucleus differentiation | 8.350849e-5 |
GO:0042574 | retinal metabolic process | 8.551227e-5 |
GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 8.735758e-5 |
GO:0021553 | olfactory nerve development | 9.485714e-5 |
GO:0051050 | positive regulation of transport | 1.007892e-4 |
GO:0033043 | regulation of organelle organization | 1.027293e-4 |
GO:0043001 | Golgi to plasma membrane protein transport | 1.028954e-4 |
GO:0010823 | negative regulation of mitochondrion organization | 1.028954e-4 |
GO:0030817 | regulation of cAMP biosynthetic process | 1.029740e-4 |
GO:0010759 | positive regulation of macrophage chemotaxis | 1.033210e-4 |
GO:0006954 | inflammatory response | 1.048397e-4 |
GO:0051240 | positive regulation of multicellular organismal process | 1.083047e-4 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 1.108608e-4 |
GO:0007600 | sensory perception | 1.120052e-4 |
GO:0032231 | regulation of actin filament bundle assembly | 1.135563e-4 |
GO:0010951 | negative regulation of endopeptidase activity | 1.136103e-4 |
GO:0002250 | adaptive immune response | 1.163697e-4 |
GO:0071712 | ER-associated misfolded protein catabolic process | 1.178129e-4 |
GO:0050778 | positive regulation of immune response | 1.183146e-4 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 1.209716e-4 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 1.266802e-4 |
GO:0010466 | negative regulation of peptidase activity | 1.286823e-4 |
GO:0002829 | negative regulation of type 2 immune response | 1.290102e-4 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 1.290102e-4 |
GO:0046826 | negative regulation of protein export from nucleus | 1.290689e-4 |
GO:0032880 | regulation of protein localization | 1.303233e-4 |
GO:0052548 | regulation of endopeptidase activity | 1.334983e-4 |
GO:0051492 | regulation of stress fiber assembly | 1.367174e-4 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 1.374779e-4 |
GO:0046825 | regulation of protein export from nucleus | 1.388462e-4 |
GO:0071897 | DNA biosynthetic process | 1.406423e-4 |
GO:0030098 | lymphocyte differentiation | 1.419389e-4 |
GO:0050922 | negative regulation of chemotaxis | 1.422312e-4 |
GO:0006097 | glyoxylate cycle | 1.445696e-4 |
GO:0006959 | humoral immune response | 1.463496e-4 |
GO:0018879 | biphenyl metabolic process | 1.479341e-4 |
GO:0006921 | cellular component disassembly involved in apoptosis | 1.494100e-4 |
GO:0031349 | positive regulation of defense response | 1.494637e-4 |
GO:0043316 | cytotoxic T cell degranulation | 1.521503e-4 |
GO:0006911 | phagocytosis, engulfment | 1.536109e-4 |
GO:0030432 | peristalsis | 1.554852e-4 |
GO:0040011 | locomotion | 1.602386e-4 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 1.616628e-4 |
GO:0043652 | engulfment of apoptotic cell | 1.616628e-4 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 1.616628e-4 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 1.616628e-4 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.616628e-4 |
GO:0043242 | negative regulation of protein complex disassembly | 1.639800e-4 |
GO:0050795 | regulation of behavior | 1.647141e-4 |
GO:0006426 | glycyl-tRNA aminoacylation | 1.669895e-4 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.675263e-4 |
GO:0046677 | response to antibiotic | 1.713892e-4 |
GO:0030593 | neutrophil chemotaxis | 1.731743e-4 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.751162e-4 |
GO:0001568 | blood vessel development | 1.781441e-4 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.797068e-4 |
GO:0010758 | regulation of macrophage chemotaxis | 1.803509e-4 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1.814050e-4 |
GO:0002253 | activation of immune response | 1.841635e-4 |
GO:0051094 | positive regulation of developmental process | 1.845876e-4 |
GO:0033124 | regulation of GTP catabolic process | 1.854985e-4 |
GO:0009605 | response to external stimulus | 1.965104e-4 |
GO:0071285 | cellular response to lithium ion | 1.968839e-4 |
GO:0032989 | cellular component morphogenesis | 1.985838e-4 |
GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process | 1.994458e-4 |
GO:0002673 | regulation of acute inflammatory response | 2.008070e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 2.040083e-4 |
GO:0050996 | positive regulation of lipid catabolic process | 2.080974e-4 |
GO:0048537 | mucosal-associated lymphoid tissue development | 2.105081e-4 |
GO:0010033 | response to organic substance | 2.258899e-4 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.294108e-4 |
GO:0060355 | positive regulation of cell adhesion molecule production | 2.346430e-4 |
GO:0070164 | negative regulation of adiponectin secretion | 2.346430e-4 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 2.346430e-4 |
GO:0006725 | cellular aromatic compound metabolic process | 2.396671e-4 |
GO:0051493 | regulation of cytoskeleton organization | 2.433572e-4 |
GO:0001754 | eye photoreceptor cell differentiation | 2.468054e-4 |
GO:0071639 | positive regulation of monocyte chemotactic protein-1 production | 2.493488e-4 |
GO:0048585 | negative regulation of response to stimulus | 2.503342e-4 |
GO:0032731 | positive regulation of interleukin-1 beta production | 2.628876e-4 |
GO:0002696 | positive regulation of leukocyte activation | 2.650831e-4 |
GO:0048514 | blood vessel morphogenesis | 2.677616e-4 |
GO:0040009 | regulation of growth rate | 2.694561e-4 |
GO:0016052 | carbohydrate catabolic process | 2.739175e-4 |
GO:0001944 | vasculature development | 2.746233e-4 |
GO:0046326 | positive regulation of glucose import | 2.852337e-4 |
GO:0016486 | peptide hormone processing | 2.888290e-4 |
GO:0034589 | hydroxyproline transport | 2.895110e-4 |
GO:0000958 | mitochondrial mRNA catabolic process | 2.895110e-4 |
GO:0015826 | threonine transport | 2.895110e-4 |
GO:0000965 | mitochondrial RNA 3'-end processing | 2.895110e-4 |
GO:0000962 | positive regulation of mitochondrial RNA catabolic process | 2.895110e-4 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 3.004303e-4 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 3.004303e-4 |
GO:0048741 | skeletal muscle fiber development | 3.040775e-4 |
GO:0043087 | regulation of GTPase activity | 3.042175e-4 |
GO:0048878 | chemical homeostasis | 3.061297e-4 |
GO:0032713 | negative regulation of interleukin-4 production | 3.145816e-4 |
GO:0017085 | response to insecticide | 3.178340e-4 |
GO:0060847 | endothelial cell fate specification | 3.313652e-4 |
GO:0050920 | regulation of chemotaxis | 3.319699e-4 |
GO:0001659 | temperature homeostasis | 3.351513e-4 |
GO:0007189 | activation of adenylate cyclase activity by G-protein signaling pathway | 3.376401e-4 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 3.385271e-4 |
GO:0030182 | neuron differentiation | 3.482698e-4 |
GO:0007155 | cell adhesion | 3.517396e-4 |
GO:0006637 | acyl-CoA metabolic process | 3.523195e-4 |
GO:0046949 | fatty-acyl-CoA biosynthetic process | 3.568882e-4 |
GO:0032369 | negative regulation of lipid transport | 3.635196e-4 |
GO:0031058 | positive regulation of histone modification | 3.637077e-4 |
GO:0051930 | regulation of sensory perception of pain | 3.691055e-4 |
GO:0006082 | organic acid metabolic process | 3.707936e-4 |
GO:0000902 | cell morphogenesis | 3.726398e-4 |
GO:0006014 | D-ribose metabolic process | 3.727702e-4 |
GO:0008283 | cell proliferation | 3.731723e-4 |
GO:0050867 | positive regulation of cell activation | 3.758537e-4 |
GO:0002711 | positive regulation of T cell mediated immunity | 3.799656e-4 |
GO:0031536 | positive regulation of exit from mitosis | 3.843169e-4 |
GO:0014050 | negative regulation of glutamate secretion | 3.894053e-4 |
GO:0048592 | eye morphogenesis | 3.929825e-4 |
GO:0051130 | positive regulation of cellular component organization | 3.936005e-4 |
GO:0046415 | urate metabolic process | 3.944918e-4 |
GO:0051346 | negative regulation of hydrolase activity | 3.965892e-4 |
GO:0022409 | positive regulation of cell-cell adhesion | 4.007124e-4 |
GO:0031279 | regulation of cyclase activity | 4.012077e-4 |
GO:0034201 | response to oleic acid | 4.121104e-4 |
GO:0019725 | cellular homeostasis | 4.191230e-4 |
GO:0030855 | epithelial cell differentiation | 4.338901e-4 |
GO:0031424 | keratinization | 4.359952e-4 |
GO:0044057 | regulation of system process | 4.370504e-4 |
GO:0009154 | purine ribonucleotide catabolic process | 4.392294e-4 |
GO:0071229 | cellular response to acid | 4.422112e-4 |
GO:0031329 | regulation of cellular catabolic process | 4.447376e-4 |
GO:0045017 | glycerolipid biosynthetic process | 4.460033e-4 |
GO:0006950 | response to stress | 4.510158e-4 |
GO:0044087 | regulation of cellular component biogenesis | 4.544011e-4 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 4.577460e-4 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 4.624668e-4 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 4.640137e-4 |
GO:0015959 | diadenosine polyphosphate metabolic process | 4.641558e-4 |
GO:0055021 | regulation of cardiac muscle tissue growth | 4.692867e-4 |
GO:0060022 | hard palate development | 4.721004e-4 |
GO:0035036 | sperm-egg recognition | 4.924212e-4 |
GO:0051339 | regulation of lyase activity | 4.998492e-4 |
GO:0033129 | positive regulation of histone phosphorylation | 5.019513e-4 |
GO:0009261 | ribonucleotide catabolic process | 5.054336e-4 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 5.110655e-4 |
GO:0009408 | response to heat | 5.208829e-4 |
GO:0046883 | regulation of hormone secretion | 5.218606e-4 |
GO:0046530 | photoreceptor cell differentiation | 5.266405e-4 |
GO:0046473 | phosphatidic acid metabolic process | 5.319590e-4 |
GO:0035284 | brain segmentation | 5.366899e-4 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 5.421336e-4 |
GO:0042851 | L-alanine metabolic process | 5.477952e-4 |
GO:0045087 | innate immune response | 5.547531e-4 |
GO:0022603 | regulation of anatomical structure morphogenesis | 5.567446e-4 |
GO:0000904 | cell morphogenesis involved in differentiation | 5.610546e-4 |
GO:0006066 | alcohol metabolic process | 5.610688e-4 |
GO:0045047 | protein targeting to ER | 5.640255e-4 |
GO:0030212 | hyaluronan metabolic process | 5.648414e-4 |
GO:0030837 | negative regulation of actin filament polymerization | 5.677176e-4 |
GO:0015825 | L-serine transport | 5.738204e-4 |
GO:0051835 | positive regulation of synapse structural plasticity | 5.803689e-4 |
GO:0043163 | cell envelope organization | 5.803689e-4 |
GO:0008616 | queuosine biosynthetic process | 5.861770e-4 |
GO:0032956 | regulation of actin cytoskeleton organization | 5.872861e-4 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5.919261e-4 |
GO:0007528 | neuromuscular junction development | 6.005991e-4 |
GO:0023057 | negative regulation of signaling | 6.084468e-4 |
GO:0051574 | positive regulation of histone H3-K9 methylation | 6.166346e-4 |
GO:0044085 | cellular component biogenesis | 6.181023e-4 |
GO:0007026 | negative regulation of microtubule depolymerization | 6.195709e-4 |
GO:0022607 | cellular component assembly | 6.283883e-4 |
GO:0032910 | regulation of transforming growth factor beta3 production | 6.323754e-4 |
GO:0060695 | negative regulation of cholesterol transporter activity | 6.388101e-4 |
GO:0010648 | negative regulation of cell communication | 6.410094e-4 |
GO:0015698 | inorganic anion transport | 6.416939e-4 |
GO:0032103 | positive regulation of response to external stimulus | 6.471053e-4 |
GO:0002819 | regulation of adaptive immune response | 6.526804e-4 |
GO:0032854 | positive regulation of Rap GTPase activity | 6.568623e-4 |
GO:0048871 | multicellular organismal homeostasis | 6.584919e-4 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 6.737941e-4 |
GO:0071236 | cellular response to antibiotic | 6.747661e-4 |
GO:0045760 | positive regulation of action potential | 6.747661e-4 |
GO:0051049 | regulation of transport | 6.774452e-4 |
GO:0090004 | positive regulation of establishment of protein localization in plasma membrane | 6.858265e-4 |
GO:0045761 | regulation of adenylate cyclase activity | 6.949107e-4 |
GO:0033632 | regulation of cell-cell adhesion mediated by integrin | 7.036661e-4 |
GO:0045646 | regulation of erythrocyte differentiation | 7.118131e-4 |
GO:0045161 | neuronal ion channel clustering | 7.224282e-4 |
GO:0009628 | response to abiotic stimulus | 7.227975e-4 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 7.268046e-4 |
GO:0032763 | regulation of mast cell cytokine production | 7.360318e-4 |
GO:0048041 | focal adhesion assembly | 7.466628e-4 |
GO:0009056 | catabolic process | 7.563061e-4 |
GO:0071637 | regulation of monocyte chemotactic protein-1 production | 7.849820e-4 |
GO:0002684 | positive regulation of immune system process | 8.143269e-4 |
GO:0046631 | alpha-beta T cell activation | 8.478384e-4 |
GO:0034340 | response to type I interferon | 8.532271e-4 |
GO:0032673 | regulation of interleukin-4 production | 8.917342e-4 |
GO:0052547 | regulation of peptidase activity | 8.957542e-4 |
GO:0010638 | positive regulation of organelle organization | 9.157401e-4 |
GO:0045070 | positive regulation of viral genome replication | 9.310412e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 9.419214e-4 |
GO:0048541 | Peyer's patch development | 9.499197e-4 |
GO:0007193 | inhibition of adenylate cyclase activity by G-protein signaling pathway | 9.576791e-4 |
GO:0016337 | cell-cell adhesion | 9.604378e-4 |
GO:0006032 | chitin catabolic process | 1.000644e-3 |
GO:0051345 | positive regulation of hydrolase activity | 1.014425e-3 |
GO:0034764 | positive regulation of transmembrane transport | 1.016193e-3 |
GO:0042127 | regulation of cell proliferation | 1.028011e-3 |
GO:0006461 | protein complex assembly | 1.029783e-3 |
GO:0006575 | cellular modified amino acid metabolic process | 1.033117e-3 |
GO:0050919 | negative chemotaxis | 1.040174e-3 |
GO:0006195 | purine nucleotide catabolic process | 1.044675e-3 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.047553e-3 |
GO:0048519 | negative regulation of biological process | 1.052366e-3 |
GO:0007416 | synapse assembly | 1.053196e-3 |
GO:0070271 | protein complex biogenesis | 1.054358e-3 |
GO:0032743 | positive regulation of interleukin-2 production | 1.066957e-3 |
GO:0001666 | response to hypoxia | 1.068470e-3 |
GO:0051704 | multi-organism process | 1.092140e-3 |
GO:0031114 | regulation of microtubule depolymerization | 1.092349e-3 |
GO:0019693 | ribose phosphate metabolic process | 1.114487e-3 |
GO:0060166 | olfactory pit development | 1.123082e-3 |
GO:0019695 | choline metabolic process | 1.128665e-3 |
GO:0006893 | Golgi to plasma membrane transport | 1.147636e-3 |
GO:0016525 | negative regulation of angiogenesis | 1.153906e-3 |
GO:0034762 | regulation of transmembrane transport | 1.157964e-3 |
GO:0060326 | cell chemotaxis | 1.172669e-3 |
GO:0021514 | ventral spinal cord interneuron differentiation | 1.180470e-3 |
GO:0002443 | leukocyte mediated immunity | 1.183489e-3 |
GO:0051495 | positive regulation of cytoskeleton organization | 1.184032e-3 |
GO:0007268 | synaptic transmission | 1.185015e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.197389e-3 |
GO:0055082 | cellular chemical homeostasis | 1.201314e-3 |
GO:0051129 | negative regulation of cellular component organization | 1.215353e-3 |
GO:0044255 | cellular lipid metabolic process | 1.223781e-3 |
GO:0031644 | regulation of neurological system process | 1.225829e-3 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 1.231839e-3 |
GO:0010755 | regulation of plasminogen activation | 1.270994e-3 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 1.290154e-3 |
GO:0051051 | negative regulation of transport | 1.290445e-3 |
GO:0042063 | gliogenesis | 1.294590e-3 |
GO:0042307 | positive regulation of protein import into nucleus | 1.304229e-3 |
GO:0006680 | glucosylceramide catabolic process | 1.316911e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0046627 | negative regulation of insulin receptor signaling pathway | 1.282270e-15 |
GO:0050896 | response to stimulus | 9.924003e-13 |
GO:0035802 | adrenal cortex formation | 9.367306e-12 |
GO:0051180 | vitamin transport | 1.084091e-11 |
GO:0046626 | regulation of insulin receptor signaling pathway | 9.804896e-11 |
GO:0006950 | response to stress | 8.030283e-10 |
GO:0032846 | positive regulation of homeostatic process | 1.484203e-9 |
GO:0031100 | organ regeneration | 1.912120e-9 |
GO:0070168 | negative regulation of biomineral tissue development | 2.713651e-9 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 4.578375e-9 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 4.578375e-9 |
GO:0007356 | thorax and anterior abdomen determination | 4.578375e-9 |
GO:0030279 | negative regulation of ossification | 6.231913e-9 |
GO:0048814 | regulation of dendrite morphogenesis | 1.324128e-8 |
GO:0030502 | negative regulation of bone mineralization | 1.513529e-8 |
GO:0032501 | multicellular organismal process | 1.770830e-8 |
GO:0032502 | developmental process | 2.434902e-8 |
GO:0031099 | regeneration | 3.649988e-8 |
GO:0072284 | metanephric S-shaped body morphogenesis | 5.012883e-8 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 5.012883e-8 |
GO:0023052 | signaling | 8.065820e-8 |
GO:0050773 | regulation of dendrite development | 9.031383e-8 |
GO:0048583 | regulation of response to stimulus | 9.576017e-8 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 1.126985e-7 |
GO:0007154 | cell communication | 1.500891e-7 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 1.841700e-7 |
GO:0045780 | positive regulation of bone resorption | 1.882004e-7 |
GO:0060923 | cardiac muscle cell fate commitment | 2.036609e-7 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 2.613894e-7 |
GO:0006952 | defense response | 2.986983e-7 |
GO:0007275 | multicellular organismal development | 3.251832e-7 |
GO:0001542 | ovulation from ovarian follicle | 3.463273e-7 |
GO:0046649 | lymphocyte activation | 3.654545e-7 |
GO:0048856 | anatomical structure development | 3.947620e-7 |
GO:0006420 | arginyl-tRNA aminoacylation | 4.942287e-7 |
GO:0045807 | positive regulation of endocytosis | 5.025633e-7 |
GO:0006955 | immune response | 6.068436e-7 |
GO:0010873 | positive regulation of cholesterol esterification | 6.502125e-7 |
GO:0042448 | progesterone metabolic process | 6.577852e-7 |
GO:0034105 | positive regulation of tissue remodeling | 8.577611e-7 |
GO:0002376 | immune system process | 9.412014e-7 |
GO:0010872 | regulation of cholesterol esterification | 9.453399e-7 |
GO:0045065 | cytotoxic T cell differentiation | 1.015930e-6 |
GO:0010951 | negative regulation of endopeptidase activity | 1.280619e-6 |
GO:0070837 | dehydroascorbic acid transport | 1.339896e-6 |
GO:0050766 | positive regulation of phagocytosis | 1.426795e-6 |
GO:0072166 | posterior mesonephric tubule development | 1.470166e-6 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 1.624850e-6 |
GO:0045911 | positive regulation of DNA recombination | 2.178885e-6 |
GO:0030728 | ovulation | 2.179367e-6 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 2.194659e-6 |
GO:0031640 | killing of cells of other organism | 2.215504e-6 |
GO:0051239 | regulation of multicellular organismal process | 2.797533e-6 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 3.029566e-6 |
GO:0048731 | system development | 3.103538e-6 |
GO:0002077 | acrosome matrix dispersal | 3.192638e-6 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 3.496462e-6 |
GO:0051716 | cellular response to stimulus | 3.984246e-6 |
GO:0051240 | positive regulation of multicellular organismal process | 4.229893e-6 |
GO:0048584 | positive regulation of response to stimulus | 4.298541e-6 |
GO:0002385 | mucosal immune response | 4.973526e-6 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 5.897979e-6 |
GO:0051883 | killing of cells in other organism involved in symbiotic interaction | 5.897979e-6 |
GO:0032957 | inositol trisphosphate metabolic process | 6.547369e-6 |
GO:0006982 | response to lipid hydroperoxide | 6.720784e-6 |
GO:0060539 | diaphragm development | 7.777949e-6 |
GO:0010898 | positive regulation of triglyceride catabolic process | 7.789745e-6 |
GO:0050775 | positive regulation of dendrite morphogenesis | 8.525678e-6 |
GO:0001944 | vasculature development | 8.788784e-6 |
GO:0046850 | regulation of bone remodeling | 9.075072e-6 |
GO:0019430 | removal of superoxide radicals | 9.108173e-6 |
GO:0002251 | organ or tissue specific immune response | 9.292100e-6 |
GO:0044243 | multicellular organismal catabolic process | 9.331399e-6 |
GO:0000305 | response to oxygen radical | 9.352343e-6 |
GO:0072539 | T-helper 17 cell differentiation | 9.784431e-6 |
GO:0001516 | prostaglandin biosynthetic process | 9.888913e-6 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 1.058248e-5 |
GO:0055090 | acylglycerol homeostasis | 1.061786e-5 |
GO:0007159 | leukocyte cell-cell adhesion | 1.066049e-5 |
GO:0001701 | in utero embryonic development | 1.102770e-5 |
GO:0032844 | regulation of homeostatic process | 1.124584e-5 |
GO:0018158 | protein oxidation | 1.142038e-5 |
GO:0033194 | response to hydroperoxide | 1.150232e-5 |
GO:0008595 | anterior/posterior axis specification, embryo | 1.387825e-5 |
GO:0045577 | regulation of B cell differentiation | 1.390244e-5 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 1.449478e-5 |
GO:0019371 | cyclooxygenase pathway | 1.590412e-5 |
GO:0007281 | germ cell development | 1.602837e-5 |
GO:0006633 | fatty acid biosynthetic process | 1.670361e-5 |
GO:0006953 | acute-phase response | 1.685248e-5 |
GO:0044003 | modification by symbiont of host morphology or physiology | 2.026607e-5 |
GO:0007165 | signal transduction | 2.047628e-5 |
GO:0042744 | hydrogen peroxide catabolic process | 2.118812e-5 |
GO:0060627 | regulation of vesicle-mediated transport | 2.146423e-5 |
GO:0048265 | response to pain | 2.256445e-5 |
GO:0032817 | regulation of natural killer cell proliferation | 2.473489e-5 |
GO:0014034 | neural crest cell fate commitment | 2.513400e-5 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 2.515839e-5 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.837833e-5 |
GO:0060421 | positive regulation of heart growth | 2.936633e-5 |
GO:0001568 | blood vessel development | 3.012197e-5 |
GO:0072273 | metanephric nephron morphogenesis | 3.057297e-5 |
GO:0045926 | negative regulation of growth | 3.325819e-5 |
GO:2000195 | negative regulation of female gonad development | 3.366799e-5 |
GO:0002440 | production of molecular mediator of immune response | 3.377899e-5 |
GO:0003006 | developmental process involved in reproduction | 3.397250e-5 |
GO:0060911 | cardiac cell fate commitment | 3.612009e-5 |
GO:0090074 | negative regulation of protein homodimerization activity | 3.815481e-5 |
GO:0051659 | maintenance of mitochondrion location | 3.843069e-5 |
GO:0042753 | positive regulation of circadian rhythm | 3.843069e-5 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 4.041618e-5 |
GO:0023051 | regulation of signaling | 4.209327e-5 |
GO:0071436 | sodium ion export | 4.460615e-5 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.460615e-5 |
GO:0045321 | leukocyte activation | 4.481435e-5 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 4.527183e-5 |
GO:2000020 | positive regulation of male gonad development | 4.936165e-5 |
GO:0048513 | organ development | 5.130514e-5 |
GO:0034103 | regulation of tissue remodeling | 5.382978e-5 |
GO:0050865 | regulation of cell activation | 5.409395e-5 |
GO:0040008 | regulation of growth | 5.416755e-5 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 5.600119e-5 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 5.631098e-5 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 5.713468e-5 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 5.861341e-5 |
GO:0019358 | nicotinate nucleotide salvage | 5.942473e-5 |
GO:0016337 | cell-cell adhesion | 5.970797e-5 |
GO:0048268 | clathrin coat assembly | 6.170400e-5 |
GO:0061032 | visceral serous pericardium development | 6.264916e-5 |
GO:0002526 | acute inflammatory response | 6.348027e-5 |
GO:0050746 | regulation of lipoprotein metabolic process | 6.624245e-5 |
GO:0030100 | regulation of endocytosis | 7.030475e-5 |
GO:0035095 | behavioral response to nicotine | 7.079931e-5 |
GO:0006901 | vesicle coating | 7.193737e-5 |
GO:0032733 | positive regulation of interleukin-10 production | 7.205091e-5 |
GO:0050668 | positive regulation of homocysteine metabolic process | 7.479944e-5 |
GO:0045963 | negative regulation of dopamine metabolic process | 7.479944e-5 |
GO:2000194 | regulation of female gonad development | 7.594919e-5 |
GO:0070904 | transepithelial L-ascorbic acid transport | 8.233239e-5 |
GO:0009311 | oligosaccharide metabolic process | 8.430967e-5 |
GO:0002227 | innate immune response in mucosa | 8.456088e-5 |
GO:0006760 | folic acid-containing compound metabolic process | 8.682744e-5 |
GO:0060395 | SMAD protein signal transduction | 8.763683e-5 |
GO:0035117 | embryonic arm morphogenesis | 8.841543e-5 |
GO:0051924 | regulation of calcium ion transport | 8.968929e-5 |
GO:0032879 | regulation of localization | 9.327315e-5 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 9.442025e-5 |
GO:0090273 | regulation of somatostatin secretion | 9.620226e-5 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 9.771680e-5 |
GO:0030838 | positive regulation of actin filament polymerization | 9.961951e-5 |
GO:0042908 | xenobiotic transport | 1.011182e-4 |
GO:0048609 | multicellular organismal reproductive process | 1.027585e-4 |
GO:0006599 | phosphagen metabolic process | 1.053688e-4 |
GO:0044130 | negative regulation of growth of symbiont in host | 1.094845e-4 |
GO:0050996 | positive regulation of lipid catabolic process | 1.094845e-4 |
GO:0045830 | positive regulation of isotype switching | 1.111499e-4 |
GO:0070541 | response to platinum ion | 1.130037e-4 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 1.176437e-4 |
GO:0002694 | regulation of leukocyte activation | 1.181768e-4 |
GO:0006471 | protein ADP-ribosylation | 1.201460e-4 |
GO:2000271 | positive regulation of fibroblast apoptosis | 1.237820e-4 |
GO:2000270 | negative regulation of fibroblast apoptosis | 1.237820e-4 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 1.237820e-4 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 1.237820e-4 |
GO:0045578 | negative regulation of B cell differentiation | 1.246330e-4 |
GO:0014043 | negative regulation of neuron maturation | 1.246330e-4 |
GO:0051657 | maintenance of organelle location | 1.296038e-4 |
GO:0060137 | maternal process involved in parturition | 1.310665e-4 |
GO:0009408 | response to heat | 1.351909e-4 |
GO:0002377 | immunoglobulin production | 1.373161e-4 |
GO:0006941 | striated muscle contraction | 1.392892e-4 |
GO:0048266 | behavioral response to pain | 1.399644e-4 |
GO:0060732 | positive regulation of inositol phosphate biosynthetic process | 1.407809e-4 |
GO:0006693 | prostaglandin metabolic process | 1.434592e-4 |
GO:0042110 | T cell activation | 1.469487e-4 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.499287e-4 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 1.520197e-4 |
GO:0006713 | glucocorticoid catabolic process | 1.568136e-4 |
GO:0050795 | regulation of behavior | 1.592927e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 1.630765e-4 |
GO:0043901 | negative regulation of multi-organism process | 1.645191e-4 |
GO:0003166 | bundle of His development | 1.798484e-4 |
GO:0009611 | response to wounding | 1.838503e-4 |
GO:0010919 | regulation of inositol phosphate biosynthetic process | 1.940884e-4 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 1.958985e-4 |
GO:0071380 | cellular response to prostaglandin E stimulus | 1.958985e-4 |
GO:0006994 | positive regulation of transcription via sterol regulatory element binding involved in ER-nuclear sterol response pathway | 1.958985e-4 |
GO:0000303 | response to superoxide | 1.963600e-4 |
GO:0003161 | cardiac conduction system development | 1.972523e-4 |
GO:0050850 | positive regulation of calcium-mediated signaling | 1.986530e-4 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.993279e-4 |
GO:0045124 | regulation of bone resorption | 2.027594e-4 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 2.061984e-4 |
GO:0072015 | glomerular visceral epithelial cell development | 2.128582e-4 |
GO:0014029 | neural crest formation | 2.128582e-4 |
GO:0030278 | regulation of ossification | 2.163602e-4 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 2.176597e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 2.176597e-4 |
GO:0061008 | hepaticobiliary system development | 2.220528e-4 |
GO:0051127 | positive regulation of actin nucleation | 2.233292e-4 |
GO:0019953 | sexual reproduction | 2.281449e-4 |
GO:0001889 | liver development | 2.373299e-4 |
GO:0048610 | cellular process involved in reproduction | 2.391434e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.428466e-4 |
GO:0006810 | transport | 2.451084e-4 |
GO:0043647 | inositol phosphate metabolic process | 2.471600e-4 |
GO:0002639 | positive regulation of immunoglobulin production | 2.496718e-4 |
GO:0002683 | negative regulation of immune system process | 2.502506e-4 |
GO:0001775 | cell activation | 2.524522e-4 |
GO:0010033 | response to organic substance | 2.540280e-4 |
GO:0034442 | regulation of lipoprotein oxidation | 2.552720e-4 |
GO:0051234 | establishment of localization | 2.556599e-4 |
GO:0030574 | collagen catabolic process | 2.558262e-4 |
GO:0008284 | positive regulation of cell proliferation | 2.558577e-4 |
GO:0014829 | vascular smooth muscle contraction | 2.561432e-4 |
GO:0060231 | mesenchymal to epithelial transition | 2.626745e-4 |
GO:0060136 | embryonic process involved in female pregnancy | 2.641764e-4 |
GO:2000018 | regulation of male gonad development | 2.641764e-4 |
GO:0060133 | somatotropin secreting cell development | 2.714882e-4 |
GO:0034553 | mitochondrial respiratory chain complex II assembly | 2.714882e-4 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 2.714882e-4 |
GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 2.726864e-4 |
GO:0008207 | C21-steroid hormone metabolic process | 2.829022e-4 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 2.901428e-4 |
GO:0015669 | gas transport | 2.910892e-4 |
GO:0006590 | thyroid hormone generation | 3.136061e-4 |
GO:0051049 | regulation of transport | 3.353976e-4 |
GO:0051607 | defense response to virus | 3.363508e-4 |
GO:0050764 | regulation of phagocytosis | 3.373273e-4 |
GO:0045137 | development of primary sexual characteristics | 3.419895e-4 |
GO:0001906 | cell killing | 3.455113e-4 |
GO:0007292 | female gamete generation | 3.489879e-4 |
GO:0007341 | penetration of zona pellucida | 3.552450e-4 |
GO:0009966 | regulation of signal transduction | 3.676079e-4 |
GO:0009948 | anterior/posterior axis specification | 3.731745e-4 |
GO:0051125 | regulation of actin nucleation | 3.747246e-4 |
GO:0007271 | synaptic transmission, cholinergic | 3.756613e-4 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 3.776702e-4 |
GO:0006107 | oxaloacetate metabolic process | 3.924081e-4 |
GO:0072358 | cardiovascular system development | 3.962670e-4 |
GO:0002706 | regulation of lymphocyte mediated immunity | 3.978943e-4 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 4.076797e-4 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 4.099524e-4 |
GO:0045663 | positive regulation of myoblast differentiation | 4.132142e-4 |
GO:0042127 | regulation of cell proliferation | 4.188453e-4 |
GO:0045766 | positive regulation of angiogenesis | 4.204986e-4 |
GO:0065007 | biological regulation | 4.207469e-4 |
GO:0006103 | 2-oxoglutarate metabolic process | 4.280693e-4 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 4.343493e-4 |
GO:0050727 | regulation of inflammatory response | 4.361813e-4 |
GO:0048537 | mucosal-associated lymphoid tissue development | 4.376866e-4 |
GO:0010591 | regulation of lamellipodium assembly | 4.376866e-4 |
GO:0006688 | glycosphingolipid biosynthetic process | 4.386396e-4 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 4.429590e-4 |
GO:0090336 | positive regulation of brown fat cell differentiation | 4.429590e-4 |
GO:0008208 | C21-steroid hormone catabolic process | 4.429590e-4 |
GO:0090271 | positive regulation of fibroblast growth factor production | 4.429590e-4 |
GO:0016192 | vesicle-mediated transport | 4.432817e-4 |
GO:0008054 | cyclin catabolic process | 4.436484e-4 |
GO:0048514 | blood vessel morphogenesis | 4.547112e-4 |
GO:0007276 | gamete generation | 4.560001e-4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 4.722572e-4 |
GO:0009247 | glycolipid biosynthetic process | 4.878516e-4 |
GO:0007585 | respiratory gaseous exchange | 4.968098e-4 |
GO:0042221 | response to chemical stimulus | 5.000501e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 5.087787e-4 |
GO:0035645 | enteric smooth muscle cell differentiation | 5.166526e-4 |
GO:0007497 | posterior midgut development | 5.166526e-4 |
GO:0014041 | regulation of neuron maturation | 5.242774e-4 |
GO:2000653 | regulation of genetic imprinting | 5.347088e-4 |
GO:0015670 | carbon dioxide transport | 5.384466e-4 |
GO:0006491 | N-glycan processing | 5.422706e-4 |
GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 5.808050e-4 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 5.827992e-4 |
GO:0003338 | metanephros morphogenesis | 5.849731e-4 |
GO:0006954 | inflammatory response | 6.275244e-4 |
GO:0060540 | diaphragm morphogenesis | 6.303845e-4 |
GO:0060464 | lung lobe formation | 6.303845e-4 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 6.341216e-4 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 6.500371e-4 |
GO:0032819 | positive regulation of natural killer cell proliferation | 6.654999e-4 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 6.690176e-4 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 6.720083e-4 |
GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process | 6.768602e-4 |
GO:0046070 | dGTP metabolic process | 6.768602e-4 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 6.768602e-4 |
GO:0045338 | farnesyl diphosphate metabolic process | 6.768602e-4 |
GO:0048520 | positive regulation of behavior | 6.804951e-4 |
GO:0010646 | regulation of cell communication | 6.813925e-4 |
GO:0051050 | positive regulation of transport | 6.869770e-4 |
GO:0007517 | muscle organ development | 6.893208e-4 |
GO:0002682 | regulation of immune system process | 6.895765e-4 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 6.927197e-4 |
GO:0003171 | atrioventricular valve development | 7.009014e-4 |
GO:0031347 | regulation of defense response | 7.036377e-4 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 7.186877e-4 |
GO:0019233 | sensory perception of pain | 7.339558e-4 |
GO:0007166 | cell surface receptor linked signaling pathway | 7.349815e-4 |
GO:0090208 | positive regulation of triglyceride metabolic process | 7.393165e-4 |
GO:0000003 | reproduction | 7.578737e-4 |
GO:0000090 | mitotic anaphase | 7.701782e-4 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 7.701782e-4 |
GO:0030490 | maturation of SSU-rRNA | 7.718836e-4 |
GO:0014821 | phasic smooth muscle contraction | 7.890195e-4 |
GO:0034435 | cholesterol esterification | 7.983396e-4 |
GO:0043496 | regulation of protein homodimerization activity | 8.041051e-4 |
GO:0070167 | regulation of biomineral tissue development | 8.116879e-4 |
GO:2000026 | regulation of multicellular organismal development | 8.342834e-4 |
GO:0033700 | phospholipid efflux | 8.590038e-4 |
GO:2000021 | regulation of ion homeostasis | 8.827485e-4 |
GO:0010592 | positive regulation of lamellipodium assembly | 8.907110e-4 |
GO:0061138 | morphogenesis of a branching epithelium | 8.926811e-4 |
GO:0060055 | angiogenesis involved in wound healing | 9.084909e-4 |
GO:0072050 | S-shaped body morphogenesis | 9.186267e-4 |
GO:0072049 | comma-shaped body morphogenesis | 9.186267e-4 |
GO:0015914 | phospholipid transport | 9.191714e-4 |
GO:0001657 | ureteric bud development | 9.211297e-4 |
GO:0072283 | metanephric renal vesicle morphogenesis | 9.304335e-4 |
GO:0035587 | purinergic receptor signaling pathway | 9.391836e-4 |
GO:0050871 | positive regulation of B cell activation | 9.434431e-4 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 9.947117e-4 |
GO:0003181 | atrioventricular valve morphogenesis | 1.024126e-3 |
GO:0030500 | regulation of bone mineralization | 1.078773e-3 |
GO:0001892 | embryonic placenta development | 1.089905e-3 |
GO:0044106 | cellular amine metabolic process | 1.120339e-3 |
GO:0006939 | smooth muscle contraction | 1.124122e-3 |
GO:0060675 | ureteric bud morphogenesis | 1.127776e-3 |
GO:0032958 | inositol phosphate biosynthetic process | 1.139212e-3 |
GO:0002268 | follicular dendritic cell differentiation | 1.172359e-3 |
GO:0000578 | embryonic axis specification | 1.191330e-3 |
GO:0097039 | protein linear polyubiquitination | 1.195784e-3 |
GO:0072520 | seminiferous tubule development | 1.195784e-3 |
GO:0051383 | kinetochore organization | 1.203028e-3 |
GO:0030382 | sperm mitochondrion organization | 1.203028e-3 |
GO:0000132 | establishment of mitotic spindle orientation | 1.230413e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.244903e-3 |
GO:0000018 | regulation of DNA recombination | 1.290641e-3 |
GO:0035050 | embryonic heart tube development | 1.297228e-3 |
GO:0008202 | steroid metabolic process | 1.313832e-3 |
GO:0031341 | regulation of cell killing | 1.314068e-3 |
GO:0022414 | reproductive process | 1.319767e-3 |
GO:0043519 | regulation of myosin II filament organization | 1.344574e-3 |
GO:0070672 | response to interleukin-15 | 1.344574e-3 |
GO:0043206 | fibril organization | 1.347317e-3 |
GO:0001893 | maternal placenta development | 1.361235e-3 |
GO:0014826 | vein smooth muscle contraction | 1.411945e-3 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 1.445708e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 1.449067e-3 |
GO:0006600 | creatine metabolic process | 1.454014e-3 |
GO:0002456 | T cell mediated immunity | 1.455989e-3 |
GO:0006090 | pyruvate metabolic process | 1.465085e-3 |
GO:0046620 | regulation of organ growth | 1.466735e-3 |
GO:0006481 | C-terminal protein methylation | 1.480589e-3 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.480589e-3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.480589e-3 |
GO:0031343 | positive regulation of cell killing | 1.503197e-3 |
GO:0008406 | gonad development | 1.505288e-3 |
GO:0046653 | tetrahydrofolate metabolic process | 1.529140e-3 |
GO:0070460 | thyroid-stimulating hormone secretion | 1.536673e-3 |
GO:0048738 | cardiac muscle tissue development | 1.540125e-3 |
GO:0060993 | kidney morphogenesis | 1.550327e-3 |
GO:0031342 | negative regulation of cell killing | 1.552960e-3 |
GO:0008594 | photoreceptor cell morphogenesis | 1.593210e-3 |
GO:0061011 | hepatic duct development | 1.593210e-3 |
GO:0051641 | cellular localization | 1.645424e-3 |
GO:0002920 | regulation of humoral immune response | 1.651090e-3 |
GO:0046394 | carboxylic acid biosynthetic process | 1.685661e-3 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 1.697588e-3 |
GO:0042304 | regulation of fatty acid biosynthetic process | 1.713680e-3 |
GO:2000507 | positive regulation of energy homeostasis | 1.731189e-3 |
GO:0001831 | trophectodermal cellular morphogenesis | 1.731189e-3 |
GO:2000253 | positive regulation of feeding behavior | 1.731189e-3 |
GO:0009617 | response to bacterium | 1.740511e-3 |
GO:0044236 | multicellular organismal metabolic process | 1.750897e-3 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 1.774591e-3 |
GO:0010959 | regulation of metal ion transport | 1.820882e-3 |
GO:0022410 | circadian sleep/wake cycle process | 1.840016e-3 |
GO:0042113 | B cell activation | 1.853548e-3 |
GO:0033555 | multicellular organismal response to stress | 1.858823e-3 |
GO:0006730 | one-carbon metabolic process | 1.870367e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 1.915396e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.915396e-3 |
GO:0021771 | lateral geniculate nucleus development | 1.915396e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.915396e-3 |
GO:0040001 | establishment of mitotic spindle localization | 1.915592e-3 |
GO:0071214 | cellular response to abiotic stimulus | 1.937620e-3 |
GO:0033554 | cellular response to stress | 1.967185e-3 |
GO:0060537 | muscle tissue development | 1.983500e-3 |
GO:0030308 | negative regulation of cell growth | 1.985099e-3 |
GO:0002637 | regulation of immunoglobulin production | 1.999329e-3 |
GO:0031344 | regulation of cell projection organization | 2.031194e-3 |
GO:0051382 | kinetochore assembly | 2.071655e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 2.081995e-3 |
GO:0016554 | cytidine to uridine editing | 2.086063e-3 |
GO:0006979 | response to oxidative stress | 2.104048e-3 |
GO:0051255 | spindle midzone assembly | 2.118740e-3 |
GO:0042592 | homeostatic process | 2.139374e-3 |
GO:0001710 | mesodermal cell fate commitment | 2.185653e-3 |
GO:0042840 | D-glucuronate catabolic process | 2.188875e-3 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 2.191717e-3 |
GO:0045747 | positive regulation of Notch signaling pathway | 2.198779e-3 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 2.246621e-3 |
GO:0048535 | lymph node development | 2.246738e-3 |
GO:0072077 | renal vesicle morphogenesis | 2.269136e-3 |
GO:0071481 | cellular response to X-ray | 2.345221e-3 |
GO:0015884 | folic acid transport | 2.345221e-3 |
GO:0051649 | establishment of localization in cell | 2.368221e-3 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 2.404990e-3 |
GO:0032101 | regulation of response to external stimulus | 2.411763e-3 |
GO:0046185 | aldehyde catabolic process | 2.419287e-3 |
GO:0005989 | lactose biosynthetic process | 2.446438e-3 |
GO:0046544 | development of secondary male sexual characteristics | 2.446438e-3 |
GO:0045579 | positive regulation of B cell differentiation | 2.450693e-3 |
GO:0009312 | oligosaccharide biosynthetic process | 2.465752e-3 |
GO:0060056 | mammary gland involution | 2.477415e-3 |
GO:0003229 | ventricular cardiac muscle tissue development | 2.514256e-3 |
GO:0050864 | regulation of B cell activation | 2.584066e-3 |
GO:0003283 | atrial septum development | 2.599006e-3 |
GO:0009719 | response to endogenous stimulus | 2.644347e-3 |
GO:0050789 | regulation of biological process | 2.662138e-3 |
GO:0009988 | cell-cell recognition | 2.699858e-3 |
GO:0050848 | regulation of calcium-mediated signaling | 2.720407e-3 |
GO:0009725 | response to hormone stimulus | 2.736791e-3 |
GO:0044281 | small molecule metabolic process | 2.737466e-3 |
GO:0060126 | somatotropin secreting cell differentiation | 2.741774e-3 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 2.741774e-3 |
GO:0033128 | negative regulation of histone phosphorylation | 2.824722e-3 |
GO:0003094 | glomerular filtration | 2.824722e-3 |
GO:0042745 | circadian sleep/wake cycle | 2.874028e-3 |
GO:0032496 | response to lipopolysaccharide | 2.892201e-3 |
GO:0006936 | muscle contraction | 2.903496e-3 |
GO:0050866 | negative regulation of cell activation | 2.912642e-3 |
GO:0050432 | catecholamine secretion | 2.926073e-3 |
GO:0071257 | cellular response to electrical stimulus | 2.944010e-3 |
GO:0051179 | localization | 2.952309e-3 |
GO:0016553 | base conversion or substitution editing | 2.954591e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 2.954591e-3 |
GO:0032653 | regulation of interleukin-10 production | 2.976955e-3 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 2.985564e-3 |
GO:0007163 | establishment or maintenance of cell polarity | 2.987364e-3 |
GO:0006575 | cellular modified amino acid metabolic process | 2.988536e-3 |
GO:0070669 | response to interleukin-2 | 3.036297e-3 |
GO:0060022 | hard palate development | 3.047068e-3 |
GO:2000027 | regulation of organ morphogenesis | 3.113510e-3 |
GO:0010613 | positive regulation of cardiac muscle hypertrophy | 3.132606e-3 |
GO:0046651 | lymphocyte proliferation | 3.182134e-3 |
GO:0071305 | cellular response to vitamin D | 3.184392e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 3.184392e-3 |
GO:0019054 | modulation by virus of host cellular process | 3.210535e-3 |
GO:0001702 | gastrulation with mouth forming second | 3.369413e-3 |
GO:0009266 | response to temperature stimulus | 3.378531e-3 |
GO:0030098 | lymphocyte differentiation | 3.378537e-3 |
GO:0032259 | methylation | 3.390937e-3 |
GO:0072028 | nephron morphogenesis | 3.456666e-3 |
GO:0003218 | cardiac left ventricle formation | 3.488595e-3 |
GO:0001573 | ganglioside metabolic process | 3.513487e-3 |
GO:0032472 | Golgi calcium ion transport | 3.517247e-3 |
GO:0032468 | Golgi calcium ion homeostasis | 3.517247e-3 |
GO:0030026 | cellular manganese ion homeostasis | 3.517247e-3 |
GO:0060420 | regulation of heart growth | 3.525135e-3 |
GO:0046456 | icosanoid biosynthetic process | 3.540455e-3 |
GO:0050873 | brown fat cell differentiation | 3.540455e-3 |
GO:0002707 | negative regulation of lymphocyte mediated immunity | 3.546084e-3 |
GO:0009628 | response to abiotic stimulus | 3.594440e-3 |
GO:0018345 | protein palmitoylation | 3.595658e-3 |
GO:0001675 | acrosome assembly | 3.598207e-3 |
GO:0002252 | immune effector process | 3.638379e-3 |
GO:0071371 | cellular response to gonadotropin stimulus | 3.670112e-3 |
GO:0006344 | maintenance of chromatin silencing | 3.689123e-3 |
GO:2000522 | positive regulation of immunological synapse formation | 3.691243e-3 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 3.691243e-3 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 3.691243e-3 |
GO:0050925 | negative regulation of negative chemotaxis | 3.731049e-3 |
GO:0048241 | epinephrine transport | 3.731070e-3 |
GO:0051004 | regulation of lipoprotein lipase activity | 3.735166e-3 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.765153e-3 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 3.779006e-3 |
GO:0006900 | membrane budding | 3.811709e-3 |
GO:0048630 | skeletal muscle tissue growth | 3.812768e-3 |
GO:0006868 | glutamine transport | 3.812768e-3 |
GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway | 3.820284e-3 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 3.827519e-3 |
GO:0019439 | aromatic compound catabolic process | 3.874073e-3 |
GO:0046622 | positive regulation of organ growth | 3.973917e-3 |
GO:0051249 | regulation of lymphocyte activation | 3.974832e-3 |
GO:0016310 | phosphorylation | 4.000181e-3 |
GO:0070849 | response to epidermal growth factor stimulus | 4.064082e-3 |
GO:0048242 | epinephrine secretion | 4.096357e-3 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 4.096357e-3 |
GO:0042098 | T cell proliferation | 4.120886e-3 |
GO:0002820 | negative regulation of adaptive immune response | 4.126005e-3 |
GO:0090276 | regulation of peptide hormone secretion | 4.162827e-3 |
GO:0050796 | regulation of insulin secretion | 4.210090e-3 |
GO:0072511 | divalent inorganic cation transport | 4.231899e-3 |
GO:0010647 | positive regulation of cell communication | 4.293947e-3 |
GO:0001821 | histamine secretion | 4.318980e-3 |
GO:0050912 | detection of chemical stimulus involved in sensory perception of taste | 4.366347e-3 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 4.398476e-3 |
GO:0006520 | cellular amino acid metabolic process | 4.414776e-3 |
GO:0022603 | regulation of anatomical structure morphogenesis | 4.425143e-3 |